中文

← All funding rounds

Biomatter

Also known as Biomatter Designs

EuropeProtein designVilnius, Lithuania, LithuaniaFounded 2018Private

Founded by researchers who met at Vilnius University's Institute of Biotechnology; designs enzymes for a customer's target reaction with generative and physics-based models, tests each design in the lab before it ships, and sells them as custom programmes to drugmakers, reagent suppliers and food, agriculture and industrial biotech companies.

Disclosed total$18M + €6.5M≈ $25.1M · in USD at each round's date
Rounds on record2
Latest round$18MSeries A · 2026-11-12
Last stated valuationNone stated
Investors named5
Research on recordNone yet

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date202520262027≈$7.13M$18M
Closed round

No research by this company is on the record yet.

Rounds and research, on one timeline

  1. 2026-11-12Series A
    Round

    $18M

    For: a 2,000 m² design-and-testing facility in Vilnius opening in 2027, a larger commercial team and US presence, and continued work on the computational platform and its enzyme dataset

    Wet labCommercial roll-outData generation

    The company's release of 12 November calls the round oversubscribed and quotes Harry Briggs of Astanor and Oliver Schoppe of UVC Partners; it was distributed on Business Wire, as TNW's report of the same day says. No valuation was disclosed.

    Lead · AstanorExisting investor · UVC PartnersExisting investor · InventureExisting investor · Metaplanet

    On the deal: Harry Briggs (Partner; spoke for the lead in the announcement, Astanor); Oliver Schoppe (Partner; spoke for the firm in the announcement, UVC Partners)

  2. 2024-08-05Seed
    Round

    €6.5M≈ $7.13M

    For: expand the platform's capabilities and design de novo enzymes

    Models and platform

    The company's release calls the round jointly led and names existing investors Practica Capital and Metaplanet as taking part, with angels and industry specialists not named.

    Co-lead · InventureCo-lead · UVC PartnersExisting investor · Practica CapitalExisting investor · Metaplanet

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

Its investors also backed

Other companies on this page whose rounds name the same investor.